Cadmium resistant bacterium, isolated from industrial wastewater, was characterized as Salmonella enterica 43C on the basis of biochemical and 16S rRNA ribotyping. It is first ever reported S. enterica 43C bared extreme resistance against heavy metal consortia in order of Pb2+>Cd2+>As3+>Zn2+>Cr6+>Cu2+>Hg2+. Cd2+ stress altered growth pattern of the bacterium in time dependent manner. It could remove nearly 57 % Cd2+ from the medium over a period of 8 days. Kinetic and thermodynamic studies based on various adsorption isotherm models (Langmuir and Freundlich) depicted the Cd2+ biosorption as spontaneous, feasible and endothermic in nature. Interestingly, the bacterium followed pseudo first order kinetics, making it a good biosorbent for heavy metal ions. The S. enterica 43C Cd2+ processivity was significantly influenced by temperature, pH, initial Cd2+ concentration, biomass dosage and co-metal ions. FTIR analysis of the bacterium revealed the active participation of amide and carbonyl moieties in Cd2+ adsorption confirmed by EDX analysis. Electron micrographs beckoned further surface adsorption and increased bacterial size due to intracellular Cd2+ accumulation. An overwhelming increase in glutathione and other non-protein thiols levels played a significant role in thriving oxidative stress generated by metal cations. Presence of metallothionein clearly depicted the role of such proteins in bacterial metal resistance mechanism. The present study results clearly declare S. enterica 43C a suitable candidate for green chemistry to bioremediate environmental Cd2+.

The ongoing episode of coronavirus disease 19 (COVID-19) has imposed a serious threat to global health and the world economy. The disease has rapidly acquired a pandemic status affecting almost all populated areas of the planet. The causative agent of COVID-19 is a novel coronavirus known as SARS-CoV-2. The virus has an approximate 30 kb single-stranded positive-sense RNA genome, which is 74.5% to 99% identical to that of SARS-CoV, CoV-pangolin, and the coronavirus the from horseshoe bat. According to available information, SARS-CoV-2 is inferred to be a recombinant virus that originated from bats and was transmitted to humans, possibly using the pangolin as the intermediate host. The interaction of the SARS-CoV-2 spike protein with the human ACE2 (angiotensin-converting enzyme 2) receptor, and its subsequent cleavage by serine protease and fusion, are the main events in the pathophysiology. The serine protease inhibitors, spike protein-based vaccines, or ACE2 blockers may have therapeutic potential in the near future. At present, no vaccine is available against COVID-19. The disease is being treated with antiviral, antimalarial, anti-inflammatory, herbal medicines, and active plasma antibodies. In this context, the present review article provides a cumulative account of the recent information regarding the viral characteristics, potential therapeutic targets, treatment options, and prospective research questions.

Most of world’s fish and seafood are produced by aquaculture, which is one of the biggest contributors to the world’s food security. The substantial increase in prices of conventional feed ingredients and the over-exploitation of natural resources are some of the biggest constraints to aquaculture production. To overcome this stress, different approaches and techniques are used, among which the use of non-conventional feed ingredients in the aquaculture sector is the most recent approach. Different non-conventional feed ingredients such as plant-based products, algae (both micro and macroalgae), single-cell protein (bacteria and yeast), and insect meal are currently used in aquaculture for sustainable food production. Amongst all these novel ingredients, insects have greater potential to replace fishmeal. The existence of about 1.3 billion tons of food and agriculture waste from the food chain supply poses a serious environmental threat. Insects are tiny creatures that can thrive on organic waste and thus can convert the waste to wealth by the bioconversion and nutritional upcycling of organic waste. Insects have the potential to recover nutrients from waste aquaculture products, and many fish species feed on insects naturally. Therefore, employing insects in the aquaculture sector to replace fishmeal is an eco-friendly approach. The present review briefly highlights emerging non-conventional feed ingredients, with special attention given to insects. The current review also focuses on the nutritional value of insects, factors affecting the nutritional value of insects, potential insects that can be employed in the aquaculture sector, the physiological response of fish when fed with insect meal, techno-functional properties of insect meal, and emerging approaches for addressing possible downsides of employing insect meal in fish diets. Finally, it suggests avenues for further research into these inventive fishmeal replacements.

Silver nanoparticles (AgNPs) are commonly used in numerous consumer products, including textiles, cosmetics, and health care items. The widespread usage of AgNPs results in their unavoidable discharge into the ecosystem, which pollutes the aquatic, groundwater, sediments, and marine environments. These nanoparticles (NPs) activate the production of free radicals reactive species in aquatic organisms that interrupt the functions of DNA, cause mitochondrial dysfunction, and increase lipid peroxidation, which terminates the development and reproduction both in vivo and in vitro. The life present in the aquatic ecosystem is becoming threatened due to the release and exploitation of AgNPs. Managing the aquatic ecosystem from the AgNP effects in the near future is highly recommended. In this review, we discussed the background of AgNPs, their discharge, and uptake by aquatic organisms, the mechanism of toxicity, different pathways of cytotoxicity, and bioaccumulation, particularly in aquatic organisms. We have also discussed the antimicrobial activities of AgNPs along with acute and chronic toxicity in aquatic groups of organisms.

The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. The Journal also features annotations, reviews, short reports, images in haematology and Letters to the Editor.